Cortex

The optimal ablation set beyond PVI for persistent AF patients remains undetermined. Should we go for an anatomical approach (e.g., PWI, VoM, LAAI) or does an personalized approach based on AF mapping still has a role? The randomized FLOW-AF trial demonstrated superiority of EGF-guided ablation vs PVI-only in redo cases (https://lnkd.in/eZNpduKG). The multicenter RESOLVE-AF study will evaluate whether active AF sources identified by OptiMap are clinically relevant in persistent AF patients undergoing their first PVI. This week we enrolled the first patient in the Erasmus MC for RESOLVE-AF. Excited to be part of this endeavor to establish the role of EGF mapping. Thanks to Marloes Jansen for the support. Sip Wijchers, Rohit Bhagwandien, Bakhtawar Khan Mahmoodi, Nick van Boven, Duke Rohlen, Melissa H. Kong, MD, Dr. Philip Haeusser, Erik Harks, Lucas Boersma #CORTEX, #EGF, #OptiMap

Continuing the enrollment in RESOLVE-AF in the Czech Republic, this week, we performed the first 5 cases at IKEM in Prague with the site principal investigator, Dr. Petr Peichl. The sub-investigators are Prof. Josef Kautzner, Dr. Dan Wichterle, and Dr. Predrag Stojadinovic. We’re grateful for their support of this study!   RESOLVE-AF is a large, prospective, multi-national trial evaluating the use of the OptiMap™ System to perform Electrographic Flow™ mapping to identify extra-pulmonary vein sources and See What Matters. Visit www.CortexEp.com to learn more about the OptiMap System. #EPeeps #EP #AF #Afib

We are grateful to have Dr. Petr Peichl and his team participating in the RESOLVE-AF trial!

Enrollment for the RESOLVE-AF trial in the Czech Republic is off to a great start! Principal Investigator Prof. Petr Neuzil and Sub-Investigator Dr. Jan Petru and their team completed their first six cases at Homolce Hospital this week.    RESOLVE-AF is a large, prospective, multi-national trial evaluating the use of the OptiMap™ System to perform Electrographic Flow™ mapping to identify extra-pulmonary vein sources and See What Matters. Visit www.CortexEp.com to learn more about the OptiMap System. #EPeeps #EP #AF #Afib

I’m fired up on the entire Ajax Health Ecosystem for creating, optimizing and institutionalizing the Ajax Growth Driver Model to drive medical device innovation. The attached Harvard Business Review article does a nice job of providing additional detail behind the model’s construct. Our model is powerful, high impact – a multifaceted alignment of activities, people, capital, strategy, development, and operating partnership. And it works, well. What we have implemented for Cordis with Cordis-X, and for Hologic, Inc. with Maverix, is what we will implement for any large strategic that is need of turn-key, off-balance sheet, turbo-charged growth. #HBR #GrowthDriver #Innovation

First cases in the Czech Republic! Congratulations to Dr. Martin Fiala and his colleagues at Neuron Medical in Brno, Czech Republic for completing their first procedures using the OptiMap™ System today! This initiates the first site in the Czech Republic in the RESOLVE-AF clinical trial. We are grateful to have Dr. Fiala as the Czech Republic PI for this study. RESOLVE-AF is a large, prospective, multi-national trial evaluating the use of the OptiMap System to perform Electrographic Flow™ mapping to identify extra-pulmonary vein sources and See What Matters. Visit www.CortexEp.com to learn more about the OptiMap System. #EPeeps #EP #AF #Afib

The Cortex team is excited to be attending the #AtrialSignals conference in Maastricht this week to share how the OptiMap™ System helps physicians See What Matters. Our CTO, Dr. Philip Haeusser gave a presentation today on how Electrographic Flow™ visualizes complex atrial arrhythmias. We’ve also enjoyed introducing people to the OptiMap™ System at our booth.   If you’d like to learn more about the OptiMap™ System, visit our website: www.CortexEP.com   We’re grateful to the Atrial Signals organizing team of Uli Schotten, Kevin Vernooy, Dominik Linz, Stef Zeemering, Jolanda Gulpen, Olaf Doessel, Axel Loewe, and Armin Luik from Maastricht University, Maastricht University Medical Centre, Karlsruhe Institute of Technology (KIT) and the Städtisches Klinikum Karlsruhe gGmbH for planning such a great conference!   #EPeeps #EP #AF #AFib

Congratulations to Dr. Tom De Potter and the #EPeeps at OLV Ziekenhuis Aalst-Asse-Ninove for completing their first two procedures using the OptiMap™ System today! This initiates the second site in Belgium in the RESOLVE-AF clinical trial. We are delighted to have Dr. de Potter and his colleagues at OLV Aalst participating in this study! RESOLVE-AF is a large, prospective, multi-national trial evaluating the use of the OptiMap System to perform Electrographic Flow™ mapping to identify extra-pulmonary vein sources and See What Matters.   Visit www.CortexEp.com to learn more about the OptiMap System. #EP #AF #Afib

First in Belgium! Congratulations to Dr. Michael Wolf and the #EPeeps at ZNA - Ziekenhuis Netwerk Antwerpen for performing Belgium's first procedure using the OptiMap™ System, as part of the RESOLVE-AF clinical trial. RESOLVE-AF is a large, prospective, multi-national trial evaluating the use of the OptiMap System to perform Electrographic Flow™ mapping to identify extra-pulmonary vein sources and See What Matters. #EP #AF #Afib

The conversations we had with the hundreds of physicians and industry professionals who came by our booth at #HRS2024 confirms our belief that the OptiMap™ System will fill a vital unmet need for understanding the underlying pathophysiology of AF, especially in complex redo cases. If you would like to See What Matters, send us a message on LinkedIn or get in touch on our website: https://lnkd.in/eCspQbwh